rs9895012
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005173.4(ATP2A3):c.2020C>T(p.Arg674Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0242 in 1,613,620 control chromosomes in the GnomAD database, including 590 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005173.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A3 | NM_005173.4 | c.2020C>T | p.Arg674Cys | missense_variant | 14/21 | ENST00000397041.8 | NP_005164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A3 | ENST00000397041.8 | c.2020C>T | p.Arg674Cys | missense_variant | 14/21 | 1 | NM_005173.4 | ENSP00000380234 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0217 AC: 3302AN: 152148Hom.: 59 Cov.: 33
GnomAD3 exomes AF: 0.0226 AC: 5610AN: 248390Hom.: 92 AF XY: 0.0224 AC XY: 3010AN XY: 134604
GnomAD4 exome AF: 0.0244 AC: 35670AN: 1461354Hom.: 531 Cov.: 33 AF XY: 0.0240 AC XY: 17483AN XY: 726986
GnomAD4 genome AF: 0.0217 AC: 3302AN: 152266Hom.: 59 Cov.: 33 AF XY: 0.0227 AC XY: 1691AN XY: 74428
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 243/12994=1.8% - |
ATP2A3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at